Status:
COMPLETED
A Biologic Joint Replacement Strategy to Treat Patients With Severe Knee Trauma and Post-Traumatic Knee Osteoarthritis
Lead Sponsor:
James Stannard
Conditions:
Post-traumatic Osteoarthritis
Eligibility:
All Genders
18-50 years
Brief Summary
With IRB approval and informed consent, patients (n=10) (18-50 years old) with post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty will ...
Eligibility Criteria
Inclusion
- Patient requiring repair via tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
- The subject is able and willing to consent to participate in the study
Exclusion
- Acute injury to any other part of the affected lower extremity
- The subject is unwilling, or unable to consent due to psychiatric condition or legal incompetence
- BMI \> 40
- Age \> 50 at the time of enrollment
- The subject is either pregnant, or a prisoner
- Currently involved in a workers' compensation case at the time of enrollment
Key Trial Info
Start Date :
December 30 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03257371
Start Date
December 30 2016
End Date
July 1 2019
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Missouri Orthopaedic Institute
Columbia, Missouri, United States, 65212